Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (17657)	1/11/1999 3:59:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

martin, The things you say Wilson needs to do should have been done 1 year ago. The Street also agrees thus the hammering of the stock price. How do you explain the current valuation? Over 2 years of significant progress yet we are 5 points below the 1994 IPO price. That's pretty sad you know: This just shows you that a few bad apples can spoil the whole barrel. Look at the progress made since about 3 years ago: 1)MUSE makes it through clinical trials and gains FDA approval (Nov'96) 2)MUSE is the best selling urological drug and one of the top 35 most successfuly launched drug in the US (1997). 3)Vivus signs international partnerships with Astra/Janssen 4)Vivus in phase III Alibra clinical trials(present). 5)Vivus has promising R&D relating to gene therapy. I can go on but why bother? Now look at the cons: 1)Vivus thinks it can compete with Pfizer and does not seek a domestic partner--instead burns through millions of cash on ineffective sales force and ineffective dirrect-to-consumer advertising. 2)Vivus blows a ton of cash buying back shares at about $15.00 share. Currently over 500% above market price. 3)Vivus has no sales force in the most lucrative market for over the past 6 months--still incapable of inking a reasonable deal for a domestic partner. The lesson to be learned is that it doesn't matter how good the product is or how big the market is, if the company is poorly managed the stock price will be punished. Thank you Mr. Wilson.